Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Prevention of Alzheimer disease.

Thal LJ.

Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S97-9. Review.

PMID:
16917204
2.

Primary prevention trials in Alzheimer disease.

Green RC, DeKosky ST.

Neurology. 2006 Nov 14;67(9 Suppl 3):S2-5. Review.

PMID:
17101930
3.

Prevention trials in Alzheimer disease: one step forward?

Touchon J, Portet F, Gauthier S.

Neurology. 2006 Nov 14;67(9 Suppl 3):S21-2. Review.

PMID:
17101931
4.

ADCS Prevention Instrument Project: overview and initial results.

Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ; Alzheimer's Disease Cooperative Study Group..

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S109-23.

PMID:
17135805
5.

Drug discovery and the prevention of Alzheimer's disease.

Fillit H.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S26-8. doi: 10.1016/j.jalz.2007.11.003. Epub 2007 Dec 21. Review.

PMID:
18631996
6.

Maintaining adherence and retention in dementia prevention trials.

DeKosky ST.

Neurology. 2006 Nov 14;67(9 Suppl 3):S14-6. Review.

PMID:
17101928
7.

Primary prevention and delay of onset of AD/dementia.

Feldman HH, Jacova C.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S84-9. Review.

PMID:
17469689
8.

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.

Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M.

NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30. Review.

9.

Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).

Meinert CL, Breitner JC.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S7-S14. doi: 10.1016/j.jalz.2007.10.007. Epub 2007 Dec 21.

PMID:
18632005
10.

Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics.

Coley N, Gallini A, Andrieu S.

CNS Drugs. 2015 Jul;29(7):519-28. doi: 10.1007/s40263-015-0256-9.

PMID:
26188654
11.

The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint.

Vellas B, Andrieu S, Ousset PJ, Ouzid M, Mathiex-Fortunet H; GuidAge Study Group..

Neurology. 2006 Nov 14;67(9 Suppl 3):S6-11. Review.

PMID:
17101932
12.
13.

Potential prevention strategies for Alzheimer disease.

Thal LJ.

Alzheimer Dis Assoc Disord. 1996 Fall;10 Suppl 1:6-8.

PMID:
8876780
14.

Designing a large prevention trial: statistical issues.

Kryscio RJ, Mendiondo MS, Schmitt FA, Markesbery WR.

Stat Med. 2004 Jan 30;23(2):285-96.

PMID:
14716729
15.

Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS.

Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):122-7. doi: 10.1097/WAD.0b013e3181f883b7.

16.

ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI).

Walsh SP, Raman R, Jones KB, Aisen PS; Alzheimer's Disease Cooperative Study Group..

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S170-8.

PMID:
17135810
17.

Community engagement in diverse populations for Alzheimer disease prevention trials.

Romero HR, Welsh-Bohmer KA, Gwyther LP, Edmonds HL, Plassman BL, Germain CM, McCart M, Hayden KM, Pieper C, Roses AD.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):269-74. doi: 10.1097/WAD.0000000000000029.

18.

ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.

Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH; Alzheimer Disease Cooperative Study Group..

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S191-202.

19.

Home-based technologies: a new paradigm for conducting dementia prevention trials.

Kaye J.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S60-6. doi: 10.1016/j.jalz.2007.10.003. Epub 2007 Dec 21. Review.

PMID:
18632003
20.

A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease.

Zhang RY, Leon AC, Chuang-Stein C, Romano SJ.

Clin Trials. 2011 Feb;8(1):5-14. doi: 10.1177/1740774510392255.

PMID:
21335586

Supplemental Content

Support Center